The further evaluation of CD57 and KLRG-1, commonly considered senescence markers on these cells, has demonstrated a significant increase of late differentiated KLRG-1+CD4+ T cells in AD patients compared with age-matched healthy controls. This evidence concerns the gene CD4 and Alzheimer disease.